Richuan Zheng

Guselkumab, a human interleukin‐23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52‐week, phase 3, multicenter, open‐label study

Shigetoshi Sano, Hiroshi Kubo, Hitomi Morishima et al. · The Journal of Dermatology · 2018 · 128 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Guselkumab, an anti‐interleukin‐23 monoclonal antibody, for the treatment of moderate to severe plaque‐type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double‐blind, placebo‐controlled study

Mamitaro Ohtsuki, Hiroshi Kubo, Hitomi Morishima et al. · The Journal of Dermatology · 2018 · 109 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis

Tadashi Terui, Satomi Kobayashi, Yukari Okubo et al. · JAMA Dermatology · 2019 · 102 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Occurrence and disease burden of respiratory syncytial virus and other respiratory pathogens in adults aged ≥65 years in community: A prospective cohort study in Japan

Daisuke Kurai, Makiko Natori, Maho Yamada et al. · Influenza and Other Respiratory Viruses · 2021 · 40 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17

Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study

Yukari Okubo, Hitomi Morishima, Richuan Zheng et al. · The Journal of Dermatology · 2021 · 32 citations · Full text

Medicine, Pharmacotherapy, Antimicrobial Pharmacotherapy +12